The GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. Br J Obstet Gynaecol. 2003;110:27–32.
Shah PS, Ye XY, Synnes A, Rouvinez-Bouali N, Yee W, Lee SK, et al. Prediction of survival without morbidity for infants born at under 33 weeks gestational age: a user-friendly graphical tool. Arch Dis Child Fetal Neonatal Ed. 2012;97:F110–5.
Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003;289:1124–9.
Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol. 2007;109:253–61.
Merialdi M, Widmer M, Gulmezoglu AM, Abdel-Aleem H, Bega G, Benachi A, et al. WHO multicentre study for the development of growth standards from fetal life to childhood: the fetal component. BMC Pregnancy Childbirth. 2014;14:157.
Article PubMed PubMed Central Google Scholar
Wareing M, Myers JE, O’Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab. 2005;90:2550–5.
Article CAS PubMed Google Scholar
Satterfield MC, Bazer FW, Spencer TE, Wu G. Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction. J Nutr. 2010;140:251–8.
Article CAS PubMed Google Scholar
Sanchez-Aparicio P, Mota-Rojas D, Nava-Ocampo AA, Trujillo-Ortega ME, Alfaro-Rodriguez A, Arch E, et al. Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia. Am J Obstet Gynaecol. 2008;198:127.e1–6.
Stanley JL, Andersson IJ, Poudel R, Rueda-Clausen CF, Sibley CP, Davidge ST, et al. Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension. 2012;59:1021–8.
Article CAS PubMed Google Scholar
von Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118:624–8.
Panda S, Das A, Md Nowroz H. Sildenafil citrate in fetal growth restriction. J Reprod Infertil. 2014;15:168–9.
PubMed PubMed Central Google Scholar
Lin TH, Su YN, Shih JC, Hsu HC, Lee CN. Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy. Ultrasound Obstet Gynecol. 2012;40:609–10.
Article CAS PubMed Google Scholar
Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci. 2012;17:632–6.
PubMed PubMed Central Google Scholar
Groom KM, McCowan LM, Mackay LK, Lee AC, Gardener G, Unterscheider J, et al. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction. BJOG. 2019;126:997–1006.
Article CAS PubMed Google Scholar
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, et al. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health. 2017. https://doi.org/10.1016/S2352-4642(17)30173-6.
Pels A, Derks J, Elvan-Taspinar A, van Drongelen J, de Boer M, Duvekot H, et al. Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA Netw Open. 2020;3:e205323.
Article PubMed PubMed Central Google Scholar
von Dadelszen P, Audibert F, Bujold E, Bone JN, Sandhu A, Li J, et al. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations. BMC Res Notes. 2022;15:244.
Groom KM, Ganzevoort W, Alfirevic Z, Lim K, Papageorghiou AT. Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium. Ultrasound Obstet Gynecol. 2018;52:295–6.
Article CAS PubMed Google Scholar
Terstappen F, Richter AE, Lely AT, Hoebeek FE, Elvan-Taspinar A, Bos AF, et al. Prenatal use of sildenafil in fetal growth restriction and its effect on neonatal tissue oxygenation-a retrospective analysis of hemodynamic data from participants of the Dutch STRIDER Trial. Front Pediatr. 2020;8:595693.
Article PubMed PubMed Central Google Scholar
Rakhanova Y, Almawi WY, Aimagambetova G, Riethmacher D. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023;23:409.
Article PubMed PubMed Central Google Scholar
Pels A, Ganzevoort W, Kenny LC, Baker PN, von Dadelszen P, Gluud C, et al. Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy. Cochrane Database Syst Rev. 2023;7:CD014498.
Hitzerd E, Broekhuizen M, Mirabito Colafella KM, Glisic M, de Vries R, Koch BCP, et al. Placental effects and transfer of sildenafil in healthy and preeclamptic conditions. EBioMedicine. 2019;45:447–55.
Article PubMed PubMed Central Google Scholar
Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial. Obstet Gynecol. 2017;129:615–20.
Article CAS PubMed Google Scholar
Turner J, Dunn L, Tarnow-Mordi W, Flatley C, Flenady V, Kumar S. Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial. Am J Obstet Gynecol. 2020;222:401–14.
Article CAS PubMed Google Scholar
De Bie FR, Basurto D, Kumar S, Deprest J, Russo FM. Sildenafil during the 2nd and 3rd trimester of pregnancy: trials and tribulations. Int J Environ Res Public Health. 2022;19:11207.
Cans C, Dolk H, Platt MJ, Colver A, Prasauskiene A, Krageloh-Mann I, et al. Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev Med Child Neurol (Suppl). 2007;109:35–8.
Gioia GA, Espy KA, Isquith PK. Behavior rating inventory of executive function, preschool version (BRIEF-P). Odessa, FL: Psychological Assessment Resources; 2003.
Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families; 2000.
Raat H, Landgraf JM, Oostenbrink R, Moll HA, Essink-Bot ML. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res. 2007;16:445–60.
Landgraf JM, Vogel I, Oostenbrink R, van Baar ME, Raat H. Parent-reported health outcomes in infants/toddlers: measurement properties and clinical validity of the ITQOL-SF47. Qual Life Res. 2013;22:635–46.
WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85.
National Heart Lung and Blood Institute. Report of the second task force on blood pressure control in children-1987. Pediatrics. 1987;79:1–25.
Spittle AJ, Treyvaud K, Doyle LW, Roberts G, Lee KJ, Inder TE, et al. Early emergence of behavior and social-emotional problems in very preterm infants. J Am Acad Child Adolesc Psychiatry. 2009;48:909–18.
Torrance HL, Bloemen MC, Mulder EJ, Nikkels PG, Derks JB, de Vries LS, et al. Predictors of outcome at 2 years of age after early intrauterine growth restriction. Ultrasound Obstet Gynecol. 2010;36:171–7.
Article CAS PubMed Google Scholar
Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 2011;37:501–14.
Article CAS PubMed Google Scholar
Pierce CM, Zhang MH, Jonsson B, Iorga D, Cheruvu N, Balagtas CC, et al. Efficacy and safety of IV sildenafil in the treatment of newborn infants with, or at risk of, persistent pulmonary hypertension of the newborn (PPHN): a multicenter, randomized, placebo-controlled trial. J Pediatr. 2021;237:154.–61.e3.
Article CAS PubMed Google Scholar
Jackson W, Gonzalez D, Smith PB, Ambalavanan N, Atz AM, Sokol GM, et al. Safety of sildenafil in extremely premature infants: a phase I trial. J Perinatol. 2022;42:31–6.
Article CAS PubMed Google Scholar
Harris SL, McKinlay C, Groom K, Beker F, Kochar A, Gill A. Neonatal cardiovascular function after antenatal sildenafil for severe, early-onset intrauterine growth restriction: a substudy of the STRIDER NZAus randomized placebo-controlled trial. J Pediatr X. 2019:1;100009.
PubMed PubMed Central Google Scholar
Yazdani A, Khoja Z, Johnstone A, Dale L, Rampakakis E, Wintermark P. Sildenafil improves brain injury recovery following term neonatal hypoxia-ischemia in male rat pups. Dev Neurosci. 2016;38:251–63.
Article CAS PubMed Google Scholar
Engels J, Elting N, Braun L, Bendix I, Herz J, Felderhoff-Müser U, et al. Sildenafil enhances quantity of immature neurons and promotes functional recovery in the developing ischemic mouse brain. Dev Neurosci. 2017;39:287–97.
Article CAS PubMed Google Scholar
Yazdani A, Howidi B, Shi MZ, Tugarinov N, Khoja Z, Wintermark P. Sildenafil improves hippocampal brain injuries and restores neuronal development after neonatal hypoxia-ischemia in male rat pups. Sci Rep. 2021;11:22046.
Comments (0)